Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate Dehydrogenase

• मुख्य लेखकों: Valerie Glutsch (लेखक), Teresa Amaral (लेखक), Claus Garbe (लेखक), Kai-Martin Thoms (लेखक), Peter Mohr (लेखक), Axel Hauschild (लेखक), Bastian Schilling (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Medical Journals Sweden, 2020-06-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

The approval of BRAF and MEK inhibitors has significantly improved treatment outcomes for patients with BRAF-mutated metastatic melanoma. The 3 first-line targeted therapy trials have provided similar results, and thus the identification of predictive biomarkers may generate a more precise basis for...